Summary
There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs.
This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes.
Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail.
Similar content being viewed by others
References
Draft guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Canberra: Commonwealth of Australia, 1995
Guidelines for economic evaluation of pharmaceuticals. 1st ed. Ottawa, Canada: CCOHTA, 1994
Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. The friction cost method for estimating the indirect costs of disease. J Health Econ 1995; 14: 171–89
Koopmanschap MA, Rutten FFH. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993; 4: 446–54
Drummond MF. Cost-of-illness studies: a major headache? Pharmacoeconomics 1992; 2: 1–4
Gerard K, Donaldson C, Maynard AK. The cost of diabetes. Diabet Med 1989; 6: 164–70
Lindgren B. Costs of illness in Sweden 1964–1975. Lund: Liber, 1981
Williams A. Economics of coronary artery bypass grafting. BMJ 1985; 291: 326–9
de Koning J, Tuyl FAWM. The relation between labour time, production and employment [In Dutch]. Rotterdam: Netherlands Economic Institute, 1984
van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labour and health status in economic evaluation of health care: the health and labour questionnaire. Int J Technol Assess Health Care. In press
van Ours J, Ridder G. Cyclical variation in vacancy durations and vacancy flows, an empirical analysis. Eur Econ Rev 1991; 35: 1143–55
Koopmanschap MA, Rutten FFH. The impact of indirect costs on outcomes of health care programs. Health Econ 1994; 3: 385–93
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koopmanschap, M.A., Rutten, F.F.H. A Practical Guide for Calculating Indirect Costs of Disease. Pharmacoeconomics 10, 460–466 (1996). https://doi.org/10.2165/00019053-199610050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199610050-00003